Graceway Pharmaceuticals, LLC Sustainability Profile
Graceway Pharmaceuticals, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a key provider of innovative healthcare solutions, focusing primarily on dermatology and other specialty areas. With a commitment to developing high-quality prescription medications, Graceway Pharmaceuticals has achieved significant milestones, including the successful launch of several unique products that address unmet medical needs. The company’s core offerings include topical treatments and therapies that stand out for their efficacy and safety profiles. Graceway's dedication to research and development has positioned it as a trusted name in the market, earning recognition for its contributions to patient care. With a strong operational presence across the US and beyond, Graceway Pharmaceuticals continues to strive for excellence in delivering effective healthcare solutions.
DitchCarbon Score
How does Graceway Pharmaceuticals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Graceway Pharmaceuticals, LLC's score of 40 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Graceway Pharmaceuticals, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Bausch Health Companies Inc., any climate commitments or emissions data would be inherited from this parent organisation. Graceway Pharmaceuticals has not publicly disclosed any specific reduction targets or initiatives related to carbon emissions. However, it is important to note that the climate commitments and performance metrics may be influenced by the broader sustainability strategies implemented by Bausch Health Companies Inc., which operates at a cascade level of 2 in relation to Graceway. As of now, Graceway Pharmaceuticals has not outlined any specific climate pledges or initiatives, nor have they reported on their participation in industry-standard frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The absence of detailed emissions data and reduction targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 19,260,000 | 00,000,000 |
How Carbon Intensive is Graceway Pharmaceuticals, LLC's Industry?
How Carbon Intensive is Graceway Pharmaceuticals, LLC's Location?
Graceway Pharmaceuticals, LLC's Scope 3 Categories Breakdown
Graceway Pharmaceuticals, LLC's Scope 3 emissions, which increased by 41% last year and increased by approximately 41% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 21% of total emissions under the GHG Protocol, with "Waste Generated in Operations" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
Graceway Pharmaceuticals, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Graceway Pharmaceuticals, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
